Information letter on Kineret® (anakinra) 100 mg and 100 mg/0.67 ml solution for injection in a pre-filled syringe: Visible solid deposits on the surface of the needle
2015.06.16
Active substance: anakinra
The Swedish company Orphan Biovitrum AB (Sobi) issues information on deposits of the active substance on the surface of the needle.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN